Effect of MMX(®) mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

BACKGROUND: MMX(®) mesalamine is a once daily oral 5-aminosalicylic acid formulation, effective in induction and maintenance of ulcerative colitis remission. Patients on long-term mesalamine maintenance may occasionally require concomitant antibiotic treatment for unrelated infections. AIM: To evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierce, David, Corcoran, Mary, Martin, Patrick, Barrett, Karen, Inglis, Susi, Preston, Peter, Thompson, Thomas N, Willsie, Sandra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029757/
https://www.ncbi.nlm.nih.gov/pubmed/24868146
http://dx.doi.org/10.2147/DDDT.S55373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029757/
https://www.ncbi.nlm.nih.gov/pubmed/24868146
http://dx.doi.org/10.2147/DDDT.S55373

Ejemplares similares